162 related articles for article (PubMed ID: 35739158)
1. Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer.
Lin X; Guo L; Lin X; Wang Y; Zhang G
Sci Rep; 2022 Jun; 12(1):10658. PubMed ID: 35739158
[TBL] [Abstract][Full Text] [Related]
2. The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity.
Zhao JW; Zhao WY; Cui XH; Xing L; Shi JC; Yu L
Clin Transl Oncol; 2024 Feb; 26(2):496-514. PubMed ID: 37407805
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of mammalian mitochondrial ribosomal protein genes.
Cheong A; Lingutla R; Mager J
Gene Expr Patterns; 2020 Dec; 38():119147. PubMed ID: 32987154
[TBL] [Abstract][Full Text] [Related]
4. MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
Cai M; Li H; Chen R; Zhou X
Cancer Manag Res; 2021; 13():2009-2024. PubMed ID: 33658859
[TBL] [Abstract][Full Text] [Related]
5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
6. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
7. A metabolic phenotype based on mitochondrial ribosomal protein expression as a predictor of lymph node metastasis in papillary thyroid carcinoma.
Lee J; Seol MY; Jeong S; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2015 Jan; 94(2):e380. PubMed ID: 25590838
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ribosomal small subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes.
Oviya RP; Gopal G; Shirley SS; Sridevi V; Jayavelu S; Rajkumar T
Gene; 2021 Jul; 790():145697. PubMed ID: 33964376
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
11. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
12. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.
Ye H; Zhang N
Comput Math Methods Med; 2021; 2021():1498924. PubMed ID: 34868337
[TBL] [Abstract][Full Text] [Related]
16. Identification and development of an independent immune-related genes prognostic model for breast cancer.
Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer.
Gao WL; Niu L; Chen WL; Zhang YQ; Huang WH
Front Genet; 2022; 13():798170. PubMed ID: 35368696
[No Abstract] [Full Text] [Related]
20. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
